Is TXG or WAY more undervalued in 2026?

CirclFi compares 10x Genomics, Inc. (TXG) and Waystar Holding Corp. (WAY) using 13 institutional-grade valuation models. TXG has a Quality of Company score of 8.3/10 while WAY scores 8.9/10.

Which is a better buy — TXG or WAY?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TXG and WAY valuations compare?

TXG at $27.99 and WAY at $19.39 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TXG vs WAY Valuation Comparison 2026 — Intrinsic Value Analysis

TXG

Health Information Services

10x Genomics, Inc.

Quality

8.3

out of 10

Value Trap

SAFE

Price

$27.99

Last close

Models

13/13

Active

WAY

Health Information Services

Waystar Holding Corp.

Quality

8.9

out of 10

Value Trap

SAFE

Price

$19.39

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	TXG Fair Value	TXG Upside	WAY Fair Value	WAY Upside
Bayesian DCF	Intrinsic	$21.21	-24.2%	$24.88	+28.3%
Earnings Power Value	Intrinsic	$5.32	-81.0%	$8.48	-56.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TXG vs WAY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TXG vs WAY — Which Stock Is More Undervalued?

WAY scores higher with a 8.9/10 quality rating vs TXG's 8.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing 10x Genomics, Inc. (TXG) and Waystar Holding Corp. (WAY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TXG currently trades at $27.99 with a QOC of 8.3/10, while WAY trades at $19.39 with a QOC of 8.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).